Legal Representation
Attorney
Michael J. Hertz
USPTO Deadlines
Next Deadline
912 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-01-18)
Due Date
January 18, 2028
Grace Period Ends
July 18, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 1, 2023 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Jul 18, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jul 18, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jul 18, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jan 18, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Nov 2, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 2, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 13, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 29, 2021 | AAUA | E | NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED | Loading... |
| Sep 28, 2021 | IUAA | P | USE AMENDMENT ACCEPTED | Loading... |
| Sep 28, 2021 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 16, 2021 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Sep 16, 2021 | AUPC | I | AMENDMENT TO USE PROCESSING COMPLETE | Loading... |
| Sep 15, 2021 | EAAU | I | TEAS AMENDMENT OF USE RECEIVED | Loading... |
| Jul 12, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 12, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 12, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 30, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 6, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 11, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Research and development of drugs and medicines for the treatment of infections, lung diseases, and skin diseases; Research and development in the pharmaceutical, life sciences, and biomedicine fields; Scientific research, testing, and analysis in the fields of pharmaceuticals, life science, and biomedicine; Medical and scientific research on lung diseases, skin diseases, infections, and cancer; Pharmaceutical products testing, analysis, research, and development
First Use Anywhere:
Jun 30, 2021
First Use in Commerce:
Jun 30, 2021
Classification
International Classes
042